Business Software Alliance President Robert Holleyman also lauded the paper, saying that he was "pleased that another important, influential organization... has joined a growing list of advocates calling for patent reform." Key critics of legislation that advanced in the House and Senate in the 110th Congress include the pharmaceutical and biotechnology industries as well as independent inventors and small firms whose business models depend largely on patent licensing. For more on the CAP report, read CongressDaily's coverage here (subscription required).